BRIEF-Ortho Regenerative Technologies Announces Successful Type A Meeting With U.S. FDA On CMC Elements
BRIEF-Ortho Regenerative Technologies Announces Successful Type A Meeting With U.S. FDA On CMC Elements
Oct 6 (Reuters) - Ortho Regenerative Technologies Inc
路透10月6日電-Ortho Regenerative Technologies Inc.
ORTH.CD :
ORTH.CD：
* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES SUCCESSFUL TYPE A MEETING WITH U.S. FDA ON CMC ELEMENTS FOR WHICH MORE INFORMATION WAS REQUIRED TO CLEAR IND CLINICAL HOLD
*Ortho Regative Technologies宣佈與美國FDA就CMC元素成功舉行A型會議，需要更多信息才能清理IND臨牀封存
* ORTHO REGENERATIVE TECHNOLOGIES INC - AGREEMENT REACHED WITH FDA ON ELEMENTAL IMPURITY TESTING USING SELECTED STANDARD REFERENCE MATERIAL
*Ortho Regative Technologies Inc-與FDA就使用選定的標準參考材料進行元素雜質測試達成協議
* ORTHO REGENERATIVE TECHNOLOGIES INC - WILL PROVIDE PROTOCOL AND TESTING RESULTS DURING COMING WEEKS
*Ortho Regenerative Technologies Inc-將在未來幾周內提供協議和測試結果
* ORTHO REGENERATIVE TECHNOLOGIES INC - PATIENT ENROLMENT STILL EXPECTED TO START BY YEAR END
*Ortho Regative Technologies Inc-患者註冊仍有望在年底前開始
* ORTHO REGENERATIVE TECHNOLOGIES - FDA HAS CONFIRMED CLINICAL HOLD WILL BE CLEARED WITHIN 30 DAYS OF SUBMISSION OF PROTOCOL AND TESTING RESULTS
*整形再生技術-FDA已確認臨牀封存將在提交方案和檢測結果後30天內獲得批准
Source text for Eikon: ID:nCNWNg8pna Further company coverage: ORTH.CD
Eikon的源文本：ID：nCNWNg8pna進一步的公司報道：ORTH.CD
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)